@daltonventure
以生命科学为根，向硬科技生长
Dalton Venture's Lin Zhencheng was invited to participate in the Future Healthcare 100 · Trend Summit to discuss the next disruptive innovation track in life sciences.
Gather friends, gather energy, gather spirit
Deep post-investment management has always been one of Dalton Venture's distinguishing strengths. How does that post-investment support ultimately translate into portfolio company growth?
Xiangxin — it's both "sunflower" + "heart," and the idea that following your inner passion lets you always grow toward the sun.
China's past economic growth was bought with high-intensity input of production factors. The only way to break through going forward is to use technology to transform production relations and shift toward high-quality development.
GPs need to buckle down and get the work done — happily.
VBData's "6th Future Healthcare 100 Conference" took "China Story" as its theme. During the heavyweight panel discussion, titled *Investing in Future Healthcare: How to Support the Emergence of World-Class Innovative Companies*, six investment firms gathered to debate how China can continue producing world-class innovators and lead at the global frontier.
